Moreover, expression of prosurvival factor Bcl-2 and aberrant PC markers (CD200, CD81, and CD269) in hscs was markedly increased in the MM cohort, reflecting clonal hematopoiesis. The gene discussed is BCL2; the disease is Miyoshi myopathy.